Log in to search using one of your social media accounts:

 

Laparoscopic Sleeve Gastrectomy: Good Operation, With Limits Laparoscopic Sleeve Gastrectomy: Good Operation, With Limits
Now the most widely performed bariatric-surgery procedure, laparoscopic sleeve gastrectomy is safer than bypass in the short term but may fall short beyond 7 years out.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Robotic-assisted or conventional laparoscopic  surgery?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2017 Category: Drugs & Pharmacology Source Type: news

Robotic Surgery: No Clinical Benefit Over Laparoscopy Robotic Surgery: No Clinical Benefit Over Laparoscopy
Patients undergoing robotic-assisted surgery appear to experience no clinical benefit compared with those having conventional laparoscopic procedures, despite a much higher cost, two studies suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 30, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

A rare case of bullhorn-injury associated traumatic hernia of anterior abdominal wall managed by laparoscopic sutured tissue-only repair - Singh KD, Singh V, Gupta P, Mani R.
Traumatic abdominal wall hernias (TAWHs) are relatively uncommon entities. Common mechanisms that predispose to such hernias include motor vehicle accidents, seat belt injuries, fall from height, handlebar injuries, and bullfighting. Bullhorn injury leadin... (Source: SafetyLit)
Source: SafetyLit - October 30, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Robotic-Assisted Surgery Adds Time, Costs Without Affecting Outcomes (CME/CE)
(MedPage Today) -- No improvements compared with laparoscopic procedures in kidney removal and rectal cancer (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - October 26, 2017 Category: Urology & Nephrology Source Type: news

Robotic Radical Nephrectomy Becoming More Common
And robotic laparoscopy for rectal cancer resection does not reduce risk for conversion to open surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 26, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Nephrology, Oncology, Surgery, Journal, Source Type: news

Robotic-assisted surgery is not always preferable to laparoscopic
Robotic-assisted surgery does not improve some outcomes in kidney removal and rectal cancer procedures Related items fromOnMedica Bariatric surgeons ’ skill doesn’t affect long-term outcomes Bed crisis leaves surgeons 'kicking their heels' Trial of robotic surgery successful for prostate cancer Shortage of critical beds and surgeons cause cancelled ops (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 25, 2017 Category: UK Health Source Type: news

Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States
TAIPEI, Taiwan, Oct. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Medeon Biodesign, Inc., a publicly traded medical device company headquartered in Taipei, is pleased to announce that its innovative laparoscopic port site closure device, AbClose™... Devices, Surgery Medeon Biodesign, AbClose, laparoscopy, port site wound closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 20, 2017 Category: Pharmaceuticals Source Type: news

TransEnterix CEO Pope, riding high on FDA nod, eyes the laparoscopic surgery market
Share prices for TransEnterix (NYSE:TRXC) have more than doubled since the robot-assisted surgery company won an important clearance from the FDA last week and CEO Todd Pope is optimistic about his companies chances against the undisputed market leader, Intuitive Surgical (NSDQ:ISRG). Morrisville, N.C.-based TransEnterix, which acquired Senhance for $100 million in September 2015, finalized its clearance bid last month after applying in April; the federal safety watchdog granted 510(k) clearance last week, pushing TRXC shares up 92.5% to a $2.81 close yesterday; the stock had ga...
Source: Mass Device - October 17, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Robotics Wall Street Beat TransEnterix Source Type: news

FDA Clears New Robotic Surgery System FDA Clears New Robotic Surgery System
The Senhance System (TransEnterix Surgical Inc) includes unique technological characteristics and is intended for use in laparoscopic colorectal and gynecologic surgery.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2017 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news

TransEnterix Thought it Could – and Did
Bringing a surgical robotic system to the U.S. market proved to be an uphill climb for TransEnterix, but just like "The Little Engine That Could," persistence paid off. FDA cleared the company's Senhance Surgical Robotic System, formerly known as the ALF-X System, late last week. The company's shares jumped more than 95% ($1.40) Monday [NYSE: TRXC] on above-average trading volume and ended the day at $2.81. Morrisville, NC-based TransEnterix acquired the system in 2015 and dedicated extra effort last year to conducting in-depth usability studies to satisfy FDA expectations. The Senhance is now...
Source: MDDI - October 16, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business Regulatory and Compliance Source Type: news

Spearheading Advancements in Surgical Sealants
Surgeons and clinicians have used surgical sealants for closing or reconnecting ruptured tissues, or as an adjunct to sutures and staples, for years. However, advancements in technology have led general surgeons and specialists to consider sealants for a wider range of applications and with increased frequency. Increasing Ease of Use Surgical sealants aren't as easy to use as a tube of Crazy Glue. Surgeons must mix and use some agents precisely and promptly to be effective. Delivery systems vary from a syringe, proprietary applicator, or through an endoscope. Most require special training. Sylys®, an elastic, resorbabl...
Source: MDDI - October 13, 2017 Category: Medical Devices Authors: Heather R. Johnson Tags: Implants Source Type: news

Olympus launches joint Sony-developed Orbeye 4K-3D video microscope
Olympus (TYO:7733) said today it launched its Orbeye 4K-3D video microscope developed by Sony Olympus Medical solutions, a joint venture between Olympus and Sony‘s (TYO:6758) Imaging Products & Solutions biz. The company said the Orbeye microscope is designed to provide high-resolution 3D imaging of the structure of tissue, blood vessels and other features to enable more accurate surgery. The system includes a 55-inch display to allow for simultaneous surgical team viewing. “The Orbeye exoscope represents the next generation of operative imaging- a true quantum shift. Its adoption is certain and w...
Source: Mass Device - October 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Olympus Sony Corp. Source Type: news

Outcome'Trade-off' With Open, Robotic Prostatectomy Outcome'Trade-off' With Open, Robotic Prostatectomy
There may be a trade-off between early recovery of erectile function and lower rates of positive surgical margins (PSMs) with robot-assisted laparoscopic radical prostatectomy and open retropubic surgery, respectively, a nonrandomized study suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 3, 2017 Category: Surgery Tags: Urology News Source Type: news

TransEnterix responds to FDA more info request
Robotics medical company TransEnterix filed its response to the Food and Drug Administration’s additional information request on its Senhance Surgical Robotic System 510(k) submission. The Senhance robotic-assisted surgery system is designed to improve minimally invasive surgery, namely in laparoscopy operations, through haptic feedback and eye sensing camera control. Get the full story at our sister site, The Robot Report. The post TransEnterix responds to FDA more info request appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - September 18, 2017 Category: Medical Devices Authors: Alex Beall Tags: Food & Drug Administration (FDA) Regulatory/Compliance Robotics Wall Street Beat TransEnterix Source Type: news

Selena Gomez Had a Kidney Transplant for Lupus. What Is That?
This article originally appeared on Health.com (Source: TIME.com: Top Science and Health Stories)
Source: TIME.com: Top Science and Health Stories - September 14, 2017 Category: Consumer Health News Authors: Amanda MacMillan / Health Tags: Uncategorized celebrities kidney transplant lupus lupus symptoms public health Selena Gomez Selena gomez disease Selena gomez Kidney Transplant Selena Gomez lupus what disease does selena gomez have What is lupus Why did selena gomez Source Type: news

Endometriosis and the gift of motherhood
When my first period came at age 13, it involved blood clots and extreme pain. I didn’t know what to expect or what was considered “normal,” but thankfully, my mother did. She recognized that my symptoms were unusual and immediately took me to see my pediatrician. I was first prescribed birth control pills, which seemed to help initially, but when my period remained heavy and painful, I was put on a different birth control pill that enabled me to have my period only four times a year. I thought my situation was normal – albeit uncomfortable and inconvenient. No one ever suggested that painful period...
Source: Thrive, Children's Hospital Boston - September 14, 2017 Category: Pediatrics Authors: Alice Hales Tags: Our Patients’ Stories Teen Health endometriosis Marc Laufer Source Type: news

Trial compares laparoscopic and open surgeries for pancreatic cancer
(Wiley) A randomized clinical trial has compared keyhole (laparoscopic) surgery and open surgery in pancreatic cancer patients undergoing pancreaticoduodenectomy, or the Whipple procedure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 13, 2017 Category: International Medicine & Public Health Source Type: news

GERD Recurrence Fairly Common Following Laparoscopic Antireflux Surgery (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Recurrence of gastroesophageal reflux disease (GERD) is relatively common among patients who have laparoscopic antireflux surgery, potentially diminishing some of the … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 12, 2017 Category: Primary Care Source Type: news

High Rate of GERD Recurrence After Antireflux Surgery High Rate of GERD Recurrence After Antireflux Surgery
Nearly 18% of patients who undergo primary laparoscopic antireflux surgery will experience recurrent gastroesophageal reflux disease requiring long-term medication or a secondary surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Acessa Health touts data from 10-year review of uterine fibroid treatment
Acessa Health today touted data from a 10-year systematic review and meta-analysis of its Acessa system designed to treat uterine fibroids and comparable procedures, touting reduced blood loss, hospitalization time and readmission rates. Data from the 10-year review was presented at the MIS Week 2017 conference by Dr. Yelena Havryliuk of Weill Cornell Medical College. The review included assessments of 143 journal articles from between 2006 and 2016 and a quantitative synthesis of 45 studies during that time, Austin, Texas-based Acessa Health said. “I have used the Acessa System and been impressed with minimal blood ...
Source: Mass Device - September 8, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Women's Health acessahealth Source Type: news

Can Next-Gen Obesity Balloon Pump Confidence in Apollo?
Apollo Endosurgery's Orbera365 weight-loss balloon works the same way as the original Orbera device, except it is designed to stay in the patient's stomach for 12 months, twice as long as the previous version. Apollo Endosurgery said it has received CE Mark approval to sell its Orbera365 weight-loss system in Europe, doubling the amount of time the balloon stays inflated in the patient's stomach. The approval comes less than a month after FDA alerted doctors of patient deaths associated with obesity balloons made by Apollo and ReShape Medical. The news deflated Apollo's stock (NASDAQ: APEN), as shares sold o...
Source: MDDI - September 6, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

MIRO trial: 3-year outcomes favor laparoscopic surgery for esophageal cancer
(European Society for Medical Oncology) Patients requiring surgery for esophageal cancer fare better after undergoing a hybrid minimally invasive esophagectomy compared to an open esophagectomy, according to long-term results of the MIRO trial to be presented at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 4, 2017 Category: Cancer & Oncology Source Type: news

Ethicon touts progress on multi-year bariatric surgery evidence initiative
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it has made major progress in its “Project Game Changer” initiative which looks to close evidence gaps and reduce clinical and economic barriers for access to surgical treatments for treating obesity and related diseases. With the Game Changer Initiative, the company said it is focusing its research and evidence generation efforts on the safety and effectiveness of bariatric surgery on reducing obesity and obesity-related diseases, including type 2 diabetes, heart diseases and orthopedic conditions. “A wide range of evidence guides i...
Source: Mass Device - August 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Surgical Weight loss Ethicon johnsonandjohnson Source Type: news

Rwanda: Indian Firm to Set Up Surgery Centre of Excellence in Rwanda
[New Times] Sunrise Group of Hospitals, a specialized consultative care and treatment centre and widely recognized as a pioneer in Laparoscopic and Endoscopic Surgeries, plans to set up a centre of excellence in Rwanda. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 28, 2017 Category: African Health Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 22, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Silver and electricity can kill bacteria: Here’s how Swedish researchers have developed a way to use silver nanoparticles and electrical currents to prevent bacteria from growing on plastic surfaces – helping to pre...
Source: Mass Device - August 22, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Titan Medical adds French hospital site to future Sport feasibility & validation study
Titan Medical (TSX:TMD) said today it inked a deal with the French Institut Hospitalo-Universitaire de Strasbourg to participate in feasibility and validation studies of its Sport robotic surgical system as the company seeks regulatory clearance for the platform. Toronto-based Titan Medical said it expects to initiate studies of its Sport system in the 4th quarter of this year, continuing into next year. “We are thrilled to partner with IHU Strasbourg, one of Europe’s premier research and training centers, for continued feasibility and validation studies for the Sport system. IHU Strasbourg is well kn...
Source: Mass Device - August 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Robot-Assisted Surgery Robotics Titan Medical Inc. Source Type: news

J & J ’ s Ethicon launches ProxiSure laparoscopic suturing device
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it launched the ProxiSure laparoscopic suturing device. Ethicon said the device features its endomechanical, suture and curved needle technologies to improve suturing precision in tight spaces. The device allows surgeons to reach desired angles, control bites and secure nots during suturing and knot tying to reduce the risk of needle loss, the company added. “With the patient’s health at the forefront of our thinking, we aimed to introduce a suturing device that will help reduce the margin of error in minimally-invasive surgery. Surgeons will n...
Source: Mass Device - August 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blog Ethicon johnsonandjohnson Source Type: news

Ethicon Launches ProxiSure(TM) Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
Advanced laparoscopic suturing device features Ethicon's innovative endomechanical, suture and curved needle technologies SOMERVILLE, N.J., Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Ethicon*, part of the Johnson & Johnson Medical Devic... Devices, Surgery, Product Launch Ethicon, Johnson & Johnson, ProxiSure, Suturing Device, laparoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 21, 2017 Category: Pharmaceuticals Source Type: news

Robot arm could revolutionise routine surgery
Laparoscopic, colorectal, prostate and ENT procedures could be simplified and made faster Related items fromOnMedica Six-month-plus surgery waits triple in four years Sharp rise in year-long waits for elective surgery Consultant-led assessments could cut unnecessary surgery Set up protocols to iron out differences in emergency surgery, hospitals told (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 21, 2017 Category: UK Health Source Type: news

Report: Olympus study of next-gen power morcellator draws criticism
Olympus (TYO:7733) is receiving criticism after moving forward with plans to revitalize its powered morcellator devices, with a new 140-patient trial planned, according to a Philadelphia Inquirer report. Power morcellators, which use a cutting tip to shred and remove uterine tissue, have been implicated in the spread of a lethal cancer that can masquerade undetected as benign fibroids. The devices designed to be used to remove benign uterine fibroids, but when used on malignant tissue, can spread cancerous cells throughout the abdomen. Olympus won FDA 510(k) clearance for a next-generation laparoscopic PK morcellator,...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Oncology Source Type: news

Intuitive Surgical licenses JustRight ’ s robotic sealing, stapling tech
Intuitive Surgical (NSDQ:ISRG) inked a license on the miniaturized robotic sealing and stapling technology developed by JustRight Surgical that includes an unspecified equity investment and joint product development program. Louisville, Colo.-based JustRight raised an $11 million Series B round early last year and later won 510(k) clearance from the FDA for its 3mm pediatric vessel-sealing system. “We are excited to team up with Intuitive Surgical to expand the impact of JustRight Surgical’s technology beyond pediatric patients,” CEO Robert Kline said in prepared remarks. “The collabo...
Source: Mass Device - August 9, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Robot-Assisted Surgery Robotics Wall Street Beat intuitivesurgical JustRight Surgical Source Type: news

Fortimedix launches short instruments for SymphonX single-port platform
Fortimedix Surgical said today it launched a shorter set of instruments for its SymphonX single-port surgical platform in the US. The newly launched product line offers shorter instrumentation for use with the SymphonX surgical platform, a single-port system designed for microlaparoscopic surgical procedures, Fortimedix said. The instrument portfolio for the SymphonX system includes products for grasping, mobilizing, dissecting, retracting, cutting, cauterizing, ligating and suction and irrigation of tissues and vessels, the Netherlands-based company said. “This product line extension was developed in response to sur...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Surgical Fortimedix Source Type: news

Mauna Kea wins FDA nod for CelioFlex Cellvizio miniprobes
Mauna Kea (ENT:MKEA) said today it won FDA 510(k) clearance for its CelioFlex UHD confocal miniprobes designed for use with its Cellvizio device in robotic-assisted surgery. The CelioFlex UHD probes are designed to provide visualization of body cavities, organs and canals during endoscopic, laparoscopic and robotic-assisted procedures, the Paris-based company said. “This new FDA clearance is an important milestone for the company on its Cellvizio product roadmap and market expansion strategy. We see the ability to instantaneously visualize and characterize tissue at the cellular level as a natural extension to r...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance Mauna Kea Technologies Source Type: news

7 medtech stories we missed this week: August 4, 2017
[Image from unsplash.com]From MDCorp inking a European distribution deal to Align Technology’s North Carolina expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. MDCorp inks distribution deal with Smart Endoscope Systems MDCorp announced in a July 31 press release that it has signed a distribution agreement with Smart Endoscope Systems, giving MDCorp permission to sell Smart’s G-Eye system throughout its European market. Neuraxon, which is in the process of merging with MDCorp, is going to be responsible for distributing the G-Eye system in Europe and a netw...
Source: Mass Device - August 4, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Food & Drug Administration (FDA) Imaging Ultrasound Vascular Weight loss Access Scientific Inc. aligntechnology Central California Blood Center Cerus Corp. FujiFilm Medical Systems MDCorp MedTech Smart Endoscope Systems Standard Source Type: news

Enteromedics wins approval for Gastric Vest study in Spain
EnteroMedics (NSDQ:ETRM) said today it won approval from Spain’s Ministry of Health, Social Services and Equality to initiate a clinical trial of its Gastric Vest system in Spain. The Gastric Vest system is a minimally invasive, laparoscopically implanted device designed to aid obese and morbidly obese patients lose weight. The device wraps around the stomach to emulate the effective of conventional weight-loss surgery, and allows for gastric volume reduction without permanent anatomical changes, EnteroMedics said. The St. Paul, Minn.-based company is looking to enroll between 50-100 patients at 4 sites wit...
Source: Mass Device - July 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Weight loss EnteroMedics Inc. Source Type: news

TransEnterix touts 1st micro-laparoscopic robotic surgeries with Senhance
TransEnterix (NYSE:TRXC) today touted that its Senhance Surgical Robot system was used in the 1st 3mm micro laparoscopic robotic surgeries globally. The surgeries were performed at France’s CHU Saint-Ètienne and at Rome’s Policlinico A. Gemelli Foundation, the Research Triangle, N.C.-based company said, by Dr. Celine Chauler, Dr. Salvatore Aletti and Dr. Gabriele Barabino. “Patients are consistently interested in the least invasive approach possible. Utilizing 3mm microlap instruments with the Senhance Surgical Robot creates a virtually scarless approach with the precision of robotics to contr...
Source: Mass Device - July 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: Robot-Assisted Surgery Robotics Surgical TransEnterix Source Type: news

Gabapentin and Postoperative Respiratory Depression Gabapentin and Postoperative Respiratory Depression
When included in multimodal analgesic regimens, is gabapentin associated with respiratory depression during post-anesthesia recovery after major laparoscopic procedures?Anesthesia & Analgesia (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Rebound Therapeutics raises $17m in Series B
Minimally invasive surgical device developer Rebound Therapeutics said today it closed a Series B round of financing, raising $16.5 million. The round was led by HBM-MedFocus, Invus Opportunities Fund and Wexford Capital affiliates, the Irvine, Calif.-based company said. Funds from the round are slated to support product develpoment, regulatory approvals, scaling up manufacturing and commercialization efforts. Rebound Threapeutics said it has developed a “unique array of devices to improve the procedural and clinical outcomes” of minimally invasive surgical procedures, and that device testing is scheduled to be...
Source: Mass Device - July 25, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Surgical reboundtherapeutics Source Type: news

Fortimedix touts results in symphonX single-port system feasibility study
Fortimedix Surgical today touted a feasibility study of its symphonX surgical platform designed for transanal colon resections, touting reduced operative trauma with the device. The Netherlands-based company touts its symphonX system as the only single-port surgery device compatible with standard 15mm laparoscopic trocar. Data from the studies were presented at the 25th  International Congress of the European Association for Endoscopic Surgery last month. Results from the studies, performed over the last 2 years by Dr. Karl-Hermann Fuchs, indicated that the device could reduce abdominal trocars and operative trau...
Source: Mass Device - July 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Surgical Fortimedix Source Type: news

Johnson & Johnson CEO Gorsky: Verb Surgical robotics program ‘ on track ’
Johnson & Johnson (NYSE:JNJ) executives yesterday said the company is “on track” with its Verb Surgical prototype robot-assisted surgery platform, with chairman & CEO Alex Gorsky labeling the healthcare giant’s approach with Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences as “computerized surgery.” “We are quite excited about our computerized surgery program. Everything up to this point in time is on track. We’re continuing to make really good progress,” Gorsky said during a conference call with analysts discussing second-quarter results. &ldquo...
Source: Mass Device - July 19, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Robot-Assisted Surgery Wall Street Beat Verb Surgical Source Type: news

Gore touts 1st commercial use of Tag thoracic stent graft
W.L. Gore & Associates said today its Tag conformable thoracic stent graft was used in its 1st commercial procedure after the system won CE Mark approval in the European Union last month. The procedure was performed by Dr. Giovanni Torsello and Dr. Martin Austermann of Munster, Germany’s St. Franziskus Hospital, the Flagstaff, Ariz.-based company said. “The enhanced control capabilities this new delivery system allows could reduce many common complications that can occur if the stent graft is not placed correctly during the TEVAR procedure. Secondary interventions can be traumatic for patients and...
Source: Mass Device - July 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Stent Grafts Vascular W.L. Gore & Associates Source Type: news

Titan Medical finds partner for Sport robotic platform feasibility, validation studies
Titan Medical (TSX:TMD) said today it inked a collaborative deal with Florida Hospital Nicholson Center to engage in a feasibility and validation study of Titan’s Sport robotic surgical system as the company seeks regulatory approval for the platform. The Toronto-based robotic surgical system developer said it expects to commence the studies in the 4th quarter, with the studies continuing into 2018. “We are delighted to enter into this agreement with Florida Hospital Nicholson Center for continued feasibility and validation studies for the Sport system. The Florida Hospital Nicholson Center is a world-clas...
Source: Mass Device - July 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Clinical Trials Robot-Assisted Surgery Robotics Titan Medical Inc. Source Type: news

Laparoscopy: illustrated
Injuries and conditions requiring keyhole surgery, including shoulder surgery, nasal surgery and laparoscopic hysterectomy. (Source: GP Online Education)
Source: GP Online Education - July 5, 2017 Category: Primary Care Tags: Surgery Source Type: news

Self-inflicted abdominal stab wounds have a higher rate of non-therapeutic laparotomy/laparoscopy and a lower risk of injury - Bugaev N, McKay K, Breeze JL, Arabian SS, Rabinovici R.
BACKGROUND: The profile and management of self-inflicted abdominal stab wounds (SI-ASW) patients is still obscure. METHODS: The National Trauma Data Bank (2012) was queried for adults with abdominal stab wounds (n  = 9544). Patients with SI-ASW (n... (Source: SafetyLit)
Source: SafetyLit - June 28, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Robot-assisted Implantation of Brachytherapy Catheters Promising in Bladder Cancer Robot-assisted Implantation of Brachytherapy Catheters Promising in Bladder Cancer
Robot-assisted laparoscopic (RAL) implantation of brachytherapy catheters (BTC) is a minimally invasive alternative to open retropubic surgery, researchers from the Netherlands report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 27, 2017 Category: Surgery Tags: Hematology-Oncology News Source Type: news

New Analytic Approach Pinpoints Laparoscopic Colectomy Savings New Analytic Approach Pinpoints Laparoscopic Colectomy Savings
Laparoscopic colectomy is more cost-effective than open surgery, with most of the savings derived from reduced use of health services after discharge and fewer readmissions, according to researchers who used a novel analytic approach known as instrumental variable analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 23, 2017 Category: Surgery Tags: General Surgery News Source Type: news

Intuitive Surgical wins FDA nod for inguinal hernia repairs with da Vinci Xi
Intuitive Surgical (NSDQ:ISRG) said today it won FDA clearance for inguinal hernia repairs with its da Vinci Xi robotic surgical system. Inguinal hernias occur when tissue presses through openings in muslces of the groin, and requires surgery to repair, the Sunnyvale, Calif.-based company said. Intuitive said that patients who undergo robotic-assisted hernia repairs experience less pain, have a low rate of returning hernias and have shorter hospital stays when compared to open or laparoscopic approaches. The da Vinci Xi surgical system provides multi-quadrant access, as well as a 3D HD view inside the body and wristed...
Source: Mass Device - June 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Robot-Assisted Surgery Robotics Intuitive Surgical Source Type: news

BD wins FDA nod for customizable mini-laparoscopic instruments
Becton Dickinson & Co. (NYSE:BDX) said today it won FDA 510(k) clearance for its line of Snowden-Pencer 3mm laparoscopic customizable surgical instruments. The line of Snowden-Pencer instruments are designed for micro-laparoscopic surgery and are intended to function like 5mm instruments, the Franklin Lakes, N.J.-based company said. Jaw lengths on the devices are designed to mirror standard laparoscopic instruments to allow for a less invasive approach without loss of functionality. “Minimally invasive micro-laparoscopic surgery is a steadily growing field resulting from patient demand for less invasive surgical ...
Source: Mass Device - June 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Surgical bectondickinson Source Type: news

BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
New Micro-Laparoscopic Instruments Offer Surgeons Less Invasive Option for Patients FRANKLIN LAKES, N.J., June 20, 2017 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology com... Devices, Surgery, FDA BD , Snowden-Pencer, laparoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2017 Category: Pharmaceuticals Source Type: news